Results for this period
Full year1 April 2025–31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
In the Techno Products Business, sales of cosmetic pen tips showed signs of recovery, while sales of pen tips for writing instruments bound for Asia, which had been strong in the first half, slowed in the second half. The Medical Products Business reported higher revenue and profit due to its focus on proactive promotional activities at domestic and overseas medical equipment exhibitions and academic conferences, together with sales activities aimed at expanding market share.
No applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | ¥6,015 million (YoY -0.3%) |
| Operating profit | ¥615 million (YoY -26.9%) |
| Ordinary income | ¥630 million (YoY -22.6%) |
| Profit attributable to owners of the parent | ¥573 million (YoY -1.2%) |
| Net income per share | ¥209.05 |
| Operating Margin | 10.2% |
| Equity ratio | End of the current fiscal period 71.3% / End of previous period 68.1% |
| Total assets | ¥10,165 million |
| Net assets | ¥7,251 million |
| Cash flows from operating activities | ¥329 million |
| Cash flows from investing activities | ¥-443 million |
| Cash flows from financing activities | ¥-148 million |
| Cash and cash equivalents at end of period | ¥2,527 million |
| Full-year earnings forecast | Net Sales To be determined / Operating profit To be determined / Ordinary income To be determined / Net income To be determined |
| Annual Dividend Forecast | ¥35 → ¥35（0.0%） |
| Payout ratio | 16.7% |
| Shareholder Return Policy | The basic policy is to return profits in line with business performance while continuing to pay stable dividends over the long term (no numerical target stated). |
| Segment revenue | Techno Products Business ¥4,236,171 thousand (YoY -2.3%), Medical Products Business ¥1,779,136 thousand (YoY +4.6%) |
| Segment profit | Techno Products Business ¥766,526 thousand (YoY -27.7%), Medical Products Business ¥161,943 thousand (YoY +31.1%) |
| Regional sales | ¥2,367,683 thousand, ¥2,646,278 thousand, ¥582,002 thousand, ¥255,451 thousand, ¥97,330 thousand, ¥66,561 thousand |
| Depreciation and amortization | ¥291,108 thousand |
| Impairment loss | No applicable matters. |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥3,957 thousand, Gain on sale of investment securities ¥1,700 thousand / Extraordinary loss Loss on Disposal of Fixed Assets ¥120 thousand |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 0 / Company name Not disclosed / Excluded Number of companies 0 / Company name Not disclosed |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | No (no eligible attendees) |
| Issued Shares at Period-End | 3,092,623 Shares |
| Treasury Shares at Period-End | 354,251 Shares |
| Factors Behind Changes in Business Performance | In the Techno Products Business, sales of cosmetic pen tips showed signs of recovery, while sales of pen tips for writing instruments bound for Asia, which had been strong in the first half, slowed in the second half. The Medical Products Business reported higher revenue and profit due to its focus on proactive promotional activities at domestic and overseas medical equipment exhibitions and academic conferences, together with sales activities aimed at expanding market share. |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the Techno Products Business, sales of pen tips for writing instruments bound for Asia, which had been strong in the first half, slowed in the second half. In the Medical Products Business, the company focused on promotional activities at domestic and overseas medical equipment exhibitions and academic conferences, as well as sales activities aimed at expanding market share. Regarding the forecast for the next fiscal year, the company cited higher raw material prices resulting from the situation in the Middle East, uncertainty over raw material procurement, supply shortages of crude oil and naphtha, and higher costs due to the weak yen and labor shortages.